HDCT and Stem Cell Transplantation for Mantle Cell and Relapsed Low Grade Non-hodgkin's Lymphoma

Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma

NCT00005631 ·Status: COMPLETED ·Phase: PHASE2

Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma

NCT01679860 ·Status: COMPLETED ·Phase: PHASE2

Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malignancies

NCT04684979 ·Status: WITHDRAWN ·Phase: PHASE2

Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host

NCT00149032 ·Status: WITHDRAWN ·Phase: PHASE2

High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas

NCT01148173 ·Status: UNKNOWN ·Phase: PHASE2

A Study of RD14-01 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma

NCT05444322 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Frontline of ASCT in High-risk DLBCL

NCT05831865 ·Status: RECRUITING

Memory Enriched T Cells Following Stem Cell Transplant in Treating Patients With Recurrent B-Cell Non-Hodgkin Lymphoma

NCT02051257 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Chemotherapy and Rituximab With or Without Total-Body Irradiation and Peripheral Stem Cell Transplant in Treating Patients With Lymphoma

NCT00039195 ·Status: COMPLETED ·Phase: PHASE2

Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients

NCT04696705 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma

NCT04977167 ·Status: RECRUITING ·Phase: PHASE1

Immunostimulatory CpG SD-101 + RT in Recurrent/Progressive Lymphoma After Allogeneic Hematopoietic Cell Transplantation (HCT)

NCT01745354 ·Status: TERMINATED ·Phase: PHASE1

Combination Chemotherapy With or Without Rituximab in Non-Hodgkin's Lymphoma

NCT00064116 ·Status: COMPLETED ·Phase: PHASE3

R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma

NCT00809341 ·Status: TERMINATED ·Phase: PHASE2

A Study of ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell Lymphoma

NCT04923789 ·Status: UNKNOWN

Allo-HSCT vs ASCT in Adult T-LBL

NCT06741813 ·Status: NOT_YET_RECRUITING ·Phase: NA

Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00058292 ·Status: COMPLETED ·Phase: PHASE1

Prospective Trial on Immunochemotherapy Plus Autologous Stem Cell Transplantation (SCT) and Allogenic SCT in Primary Mantle-Cell-Lymphoma

NCT00946374 ·Status: UNKNOWN ·Phase: PHASE2

Treatment of Localized Low Grade Lymphomas

NCT00536458 ·Status: COMPLETED ·Phase: PHASE3

Transplantation After Complete Response In Patients With T-cell Lymphoma

NCT05444712 ·Status: RECRUITING ·Phase: NA

Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL

NCT05554939 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Feasibility Study Of Adding Bortezomib to R-ICE Chemotherapy To Treat Relapsed/ Refractory Diffuse Large B-Cell Lymphoma

NCT01226849 ·Status: COMPLETED ·Phase: PHASE1

Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment

NCT00324467 ·Status: UNKNOWN ·Phase: PHASE2

Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)

NCT00368082 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30)

NCT01316146 ·Status: WITHDRAWN ·Phase: PHASE1